Early diagnostics reduce healthcare costs; improve quality of life

Recently, PerkinElmer CEO Robert Friel was interviewed on FOX Business News to discuss the state of the nation’s healthcare—and how the global life sciences company is doing its part to ensure a healthier future for all. The parent company of ViaCord, PerkinElmer designs and delivers advanced technology solutions that address the world’s most critical health and safety concerns. For example, PerkinElmer is the leading worldwide provider of neonatal screening systems that have helped identify more than 100,000 newborns at risk of inherited metabolic disorders.

In the FOX interview, Mr. Friel stressed the importance of early diagnostics in keeping health care costs down and improving quality of life. For instance, by opting into newborn screening programs for early detection of health threats, parents may be able to help their child receive therapeutic intervention earlier, leading to a more successful outcome. There is often a positive financial outcome as well—early awareness and intervention can help families avoid costly procedures further down the line and improve quality of life, which also reduces costs for employers, insurers and healthcare institutions.

In the United States, while there is much debate about healthcare reform, we can all agree on one thing: everyone benefits from controlling the costs of healthcare while creating more successful outcomes. For ViaCord and PerkinElmer, we believe in providing healthcare options for the better—options that can help families be better informed, better aware, and better protected.

• Watch Mr. Friel’s interview
• Learn more about PerkinElmer
  
• And weigh in: do you have a first-hand experience with early diagnostics improving quality of life for someone you love?

To automatically receive our blog posts, sign-up to receive an email or register for our RSS feed.